BridgeMD
New treatment option for Generalized Anxiety Disorder (GAD)
Official title EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety Disorder
ClinicalTrials.gov ID: NCT06811311
What this study is testing
- What it's testing
- This study examines the neurophysiological and psychological effects of Ericksonian hypnotherapy in individuals diagnosed with Generalized Anxiety Disorder (GAD). Using electroencephalography (EEG), the study aims to assess changes in brain activity and anxiety symptoms before and after treatment.
- Time commitment: about 12 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Diagnosis of Generalized Anxiety Disorder (GAD) based on DSM-5 criteria
- Aged 18-65 years
- Capable of providing written informed consent
- Fluent in Turkish (for hypnosis and assessments)
- Not currently receiving psychotherapy or pharmacological treatment for anxiety
You likely can't join if
- Presence of comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depression requiring immediate intervention)
- History of neurological conditions (e.g., epilepsy, traumatic brain injury, stroke)
- Current use of medications affecting EEG activity (e.g., benzodiazepines, SSRIs, antipsychotics)
- Previous experience with hypnotherapy (to avoid expectancy bias)
- Substance abuse or dependence within the last six months
- Pregnancy or breastfeeding
See the full eligibility criteria
- Diagnosis of Generalized Anxiety Disorder (GAD) based on DSM-5 criteria
- Aged 18-65 years
- Capable of providing written informed consent
- Fluent in Turkish (for hypnosis and assessments)
- Not currently receiving psychotherapy or pharmacological treatment for anxiety
- Presence of comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depression requiring immediate intervention)
- History of neurological conditions (e.g., epilepsy, traumatic brain injury, stroke)
- Current use of medications affecting EEG activity (e.g., benzodiazepines, SSRIs, antipsychotics)
- Previous experience with hypnotherapy (to avoid expectancy bias)
- Substance abuse or dependence within the last six months
- Pregnancy or breastfeeding
- Severe medical conditions that may interfere with participation
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.